{"id":"W3113288931","doi":"10.1016/j.annonc.2020.10.562","title":"74P Pivotal trial 201 data on outpatient administration of naxitamab (Hu3F8), a humanized GD2 targeted immunotherapy for the treatment of refractory/relapsed (R/R) high-risk (HR) neuroblastoma (NB)","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Internal medicine; Refractory (planetary science); Population; Dosing; Outpatient clinic; Surgery; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001135341,0.001069195,0.001699692,0.0002323753,0.0003778572,0.001281341,0.0008587771,0.001812067,0.01924029],"category_scores_gemma":[0.001944732,0.0003288933,0.001651736,0.0003858129,0.000532833,0.0005681054,0.0003214485,0.004591322,0.004208378],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001376008,"about_ca_system_score_gemma":0.002552236,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002762162,"about_ca_topic_score_gemma":0.007765476,"domain_scores_codex":[0.9995483,0.0002285258,0.00001819953,0.00005623047,0.00005613848,0.00009263866],"domain_scores_gemma":[0.9991578,0.0002387665,0.0001478375,0.00007904092,0.00007809132,0.0002985054],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6202676,0.005292139,0.002009002,0.003281418,0.002598546,0.0005058614,0.0001242258,0.002495182,0.01682796,0.003019061,0.1553328,0.1882462],"study_design_scores_gemma":[0.7475572,0.07794007,0.0090989,0.0006392404,0.001405509,0.0007430567,0.00007079374,0.001346813,0.002859205,0.002497092,0.1557722,0.00007000969],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6041016,0.05513263,0.006602184,0.03271152,0.01014362,0.01044201,0.1109842,0.001819474,0.1680628],"genre_scores_gemma":[0.7748654,0.02327012,0.007138683,0.03069087,0.001882299,0.006296484,0.07689532,0.0004780037,0.07848273],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01924029,"threshold_uncertainty_score":0.06436521,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1655488760139933,"score_gpt":0.4172979653210983,"score_spread":0.251749089307105,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}